Related references
Note: Only part of the references are listed.Durable cell and gene therapy potential patient and financial impact: US projections of product approvals, patients treated, and product revenues
Colin M. Young et al.
DRUG DISCOVERY TODAY (2022)
Gene therapy access: Global challenges, opportunities, and views from Brazil, South Africa, and India
Kenneth Cornetta et al.
MOLECULAR THERAPY (2022)
The viral capsid as novel nanomaterials for drug delivery
Alaa A. A. Aljabali et al.
FUTURE SCIENCE OA (2021)
Royal gene therapy at a royal cost Comment
Margaret Ragni
BLOOD (2021)
Current Clinical Applications of In Vivo Gene Therapy with AAVs
Jerry R. Mendell et al.
MOLECULAR THERAPY (2021)
The clinical landscape for AAV gene therapies
Dmitry A. Kuzmin et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Ubiquitination on Lysine 247 of Newcastle Disease Virus Matrix Protein Enhances Viral Replication and Virulence by Driving Nuclear-Cytoplasmic Trafficking
Tingyu Peng et al.
JOURNAL OF VIROLOGY (2021)
Epithelial cells remove precancerous cells by cell competition via MHC class I-LILRB3 interaction
Shiyu Ayukawa et al.
NATURE IMMUNOLOGY (2021)
Adeno-associated virus capsid assembly is divergent and stochastic
Tobias P. Woerner et al.
NATURE COMMUNICATIONS (2021)
Virus-like particles: preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers
Saghi Nooraei et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
Adeno-Associated Viruses (AAV) and Host Immunity - A Race Between the Hare and the Hedgehog
Kleopatra Rapti et al.
FRONTIERS IN IMMUNOLOGY (2021)
Virus self-assembly proceeds through contact-rich energy minima
Pedro Buzon et al.
SCIENCE ADVANCES (2021)
Assessment of quality attributes for adeno-associated viral vectors
Andrew D. Tustian et al.
BIOTECHNOLOGY AND BIOENGINEERING (2021)
SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles
Caroline B. Plescia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer
Helena Costa Verdera et al.
MOLECULAR THERAPY (2020)
Physical virology: From virus self-assembly to particle mechanics
Pedro Buzon et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2020)
Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
Giuseppe Ronzitti et al.
FRONTIERS IN IMMUNOLOGY (2020)
Synthetically Engineered Adeno-Associated Virus for Efficient, Safe, and Versatile Gene Therapy Applications
Margaret L. Lugin et al.
ACS NANO (2020)
Virus-like nanoparticles as a novel delivery tool in gene therapy
Jaison Jeevanandam et al.
BIOCHIMIE (2019)
Adeno-associated virus vector as a platform for gene therapy delivery
Dan Wang et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
AAV-based gene therapies for the muscular dystrophies
Julie M. Crudele et al.
HUMAN MOLECULAR GENETICS (2019)
Advances and challenges for hemophilia gene therapy
Paul Batty et al.
HUMAN MOLECULAR GENETICS (2019)
Measurements of the self-assembly kinetics of individual viral capsids around their RNA genome
Rees F. Garmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Pharmacology of Recombinant Adeno-associated Virus Production
Magalie Penaud-Budloo et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Helper-free Production of Laboratory Grade AAV and Purification by lodixanol Density Gradient Centrifugation
Sean M. Crosson et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Emerging Issues in AAV-Mediated In Vivo Gene Therapy
Pasqualina Colella et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Molecular design for recombinant adeno-associated virus (rAAV) vector production
Juan Jose Aponte-Ubillus et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2018)
AAV: An Overview of Unanswered Questions
Kenneth I. Berns et al.
HUMAN GENE THERAPY (2017)
Palmitoylation Contributes to Membrane Curvature in Influenza A Virus Assembly and Hemagglutinin-Mediated Membrane Fusion
Petr Chlanda et al.
JOURNAL OF VIROLOGY (2017)
Cytoplasmic Motifs in the Nipah Virus Fusion Protein Modulate Virus Particle Assembly and Egress
Gunner P. Johnston et al.
JOURNAL OF VIROLOGY (2017)
The function of DNA binding protein nucleophosmin in AAV replication
Stifani Satkunanathan et al.
VIROLOGY (2017)
Improving the Quality of Adeno-Associated Viral Vector Preparations: The Challenge of Product-Related Impurities
Maria Schnoedt et al.
HUMAN GENE THERAPY METHODS (2017)
A Robust System for Production of Superabundant VP1 Recombinant AAV Vectors
Qizhao Wang et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
Thermal Stability as a Determinant of AAV Serotype Identity
Antonette Bennett et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
Basic Biology of Adeno-Associated Virus (AAV) Vectors Used in Gene Therapy
Balaji Balakrishnan et al.
CURRENT GENE THERAPY (2014)
Establishment of a Novel Cell Line for the Enhanced Production of Recombinant Adeno-Associated Virus Vectors for Gene Therapy
Stifani Satkunanathan et al.
HUMAN GENE THERAPY (2014)
The special case of gene therapy pricing
Troyen A. Brennan et al.
NATURE BIOTECHNOLOGY (2014)
AAV-Mediated Gene Therapy for Research and Therapeutic Purposes
R. Jude Samulski et al.
ANNUAL REVIEW OF VIROLOGY, VOL 1 (2014)
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
Peter Pushko et al.
INTERVIROLOGY (2013)
Comparative Analysis of Adeno-Associated Virus Capsid Stability and Dynamics
Vamseedhar Rayaprolu et al.
JOURNAL OF VIROLOGY (2013)
Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development
Natasha Kushnir et al.
VACCINE (2012)
Universal Real-Time PCR for the Detection and Quantification of Adeno-Associated Virus Serotype 2-Derived Inverted Terminal Repeat Sequences
Christine Aurnhammer et al.
HUMAN GENE THERAPY METHODS (2012)
The Assembly-Activating Protein Promotes Capsid Assembly of Different Adeno-Associated Virus Serotypes
F. Sonntag et al.
JOURNAL OF VIROLOGY (2011)
AAV-mediated gene targeting methods for human cells
Iram F. Khan et al.
NATURE PROTOCOLS (2011)
SOCS1 is an inducible host factor during HIV-1 infection and regulates the intracellular trafficking and stability of HIV-1 Gag
Akihide Ryo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Virus-like particles: Passport to immune recognition
Elizabeth V. L. Grgacic et al.
METHODS (2006)
Expression of the adenovirus E4 34k oncoprotein inhibits repair of double strand breaks in the cellular genome of a 293-based inducible cell line
ES Mohammadi et al.
NUCLEIC ACIDS RESEARCH (2004)
Virus entry: Molecular mechanisms and biomedical applications
DS Dimitrov
NATURE REVIEWS MICROBIOLOGY (2004)
Systemic delivery of genes to striated muscles using adeno-associated viral vectors
P Gregorevic et al.
NATURE MEDICINE (2004)
Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging
K Luo et al.
JOURNAL OF VIROLOGY (2004)
Human papillomavirus type 6b virus-like particles are able to activate the Ras-MAP kinase pathway and induce cell proliferation
E Payne et al.
JOURNAL OF VIROLOGY (2001)
Share Paper
